Sarepta Therapeutics | SRPT - EPS Earnings Per Share


Sarepta Therapeutics reported $3.16 in EPS Earnings Per Share for its fiscal quarter ending in March of 2026.


Fiscal Calendar Actual Consensus Previous Date
FY2026Q3 Sep/2025 0.23 -0.13 Nov/04
FY2026Q2 Jun/2026 0.21 2.02 Aug/05
FY2026Q1 Mar/2026 3.16 1.11 -3.42 May/06
FY2025Q4 Dec/2025 -3.58 -1.27 1.90 Feb/25
FY2025Q3 Sep/2025 -0.13 -0.6 0.62 Nov/03




Eps Change Date
Acadia Pharmaceuticals USD 0.02 1.58 Mar/2026
Agios Pharmaceuticals USD -1.69 0.17 Mar/2026
Alnylam Pharmaceuticals USD 1.99 0.74 Mar/2026
Amgen USD 5.15 0.14 Mar/2026
BioCryst Pharmaceuticals USD 1.17 1.1 Dec/2025
Biogen USD 3.57 1.58 Mar/2026
BioMarin Pharmaceutical USD 0.76 0.3 Mar/2026
Capricor Therapeutics USD -0.62 0.08 Dec/2025
Daiichi Sankyo JPY 48.75 1.96 Mar/2026
Eli Lilly USD 8.55 1.01 Mar/2026
Gilead Sciences USD 2.03 0.17 Mar/2026
Incyte USD 1.81 0.01 Mar/2026
Insmed USD -0.76 0.78 Mar/2026
Ionis Pharmaceuticals USD -0.56 0.85 Mar/2026
Moderna USD -3.4 1.29 Mar/2026
Nektar Therapeutics USD -1.35 1.17 Dec/2025
Neurocrine Biosciences USD 1.94 0.06 Mar/2026
Novavax USD 0.13 0.59 Dec/2025
Pfizer USD 0.75 0.09 Mar/2026
PTC Therapeutics USD -0.03 1.64 Mar/2026
Regeneron Pharmaceuticals USD 9.47 1.97 Mar/2026
Roche Holding CHF 10.98 2.61 Jun/2026
Sangamo BioSciences USD -0.18 0.1 Jun/2024
Sanofi EUR 1.88 0.35 Mar/2026
Sarepta Therapeutics USD 3.16 6.74 Mar/2026
Tectonic Therapeutic USD -1.34 0.32 Mar/2026
Ultragenyx Pharmaceutical USD -1.84 0.55 Mar/2026
Vertex Pharmaceuticals USD 4.47 0.56 Mar/2026